Priapism associated with anti-seizure medications: a pharmacovigilance study and a review of published cases
- 11 December 2023
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 23 (1) , 67-78
Abstract
BackgroundRecently, case reports of priapism associated with the use of some anti-seizure medications began to emerge in the literature. We aimed to investigate if there is a potential safety signal of priapism among individual anti-seizure medications and to search the literature for relevant published cases.Research design and methodsWe conducted a disproportionality analysis using OpenVigil 2.1 to query the United States Food and Drug Administration's Adverse Event Reporting System (FAERS) database. Literature search was conducted in PubMed/MEDLINE, Scopus and Web of Science up to 12 July 2023.ResultsWe identified positive signal of priapism for valproic acid and its derivatives (n = 23, chi-squared = 59.943, PRR = 4.566), gabapentin (n = 20, chi-squared = 9.790, PRR = 2.060), lamotrigine (n = 16, chi-squared = 8.318, PRR = 2.120), levetiracetam (n = 16, chi-squared = 10.766, PRR = 2.329), topiramate (n = 14, chi-squared = 28.067, PRR = 3.972) and carbamazepine (n = 8, chi-squared = 6.147, PRR = 2.568), as well as published cases of priapism associated with these drugs. We also found published cases of priapism for pregabalin and phenytoin in the literature and FAERS, and at least one reported adverse event of priapism in FAERS for clonazepam, lacosamide, ethosuximide, oxcarbazepine, and vigabatrin in which they were considered primary suspect.ConclusionsOur study identified signals for priapism for several anti-seizure medications, but these results need to be confirmed in well-designed pharmacoepidemiological studies.Keywords
Funding Information
- Ministry of Science, Technological Development and Innovations of Republic of Serbia (contract no. 451-03-47/2023-01/200111)
This publication has 36 references indexed in Scilit:
- European Association of Urology Guidelines on PriapismEuropean Urology, 2014
- Sodium Valproate induced priapism in an adult with bipolar affective disorderIndian Journal of Pharmacology, 2013
- Adverse Reaction Signaling and Disproportionality Analysis: An UpdateDrug Information Journal, 2012
- OpenVigil—free eyeballs on AERS pharmacovigilance dataNature Biotechnology, 2012
- Carbamazepine Associated Prolonged Erection in a Patient with Bipolar DisorderJournal of Mood Disorders, 2012
- Priapism Associated with Phenytoin ToxicityBritish Journal of Medical and Surgical Urology, 2009
- PRIAPISM ASSOCIATED WITH OXCARBAZEPINE, ARIPIPRAZOLE, AND LITHIUMJournal of the American Academy of Child & Adolescent Psychiatry, 2005
- Gabapentin in the management of the recurrent, refractory, idiopathic priapismInternational Journal Of Impotence Research, 2004
- Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reportsPharmacoepidemiology and Drug Safety, 2001
- Priapism After a Suicide Attempt by Ingestion of Olanzapine and GabapentinPsychosomatics, 2001